Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stock Options of Board

S&L-teremoto,

in response to by
posted on Nov 16, 2007 04:42PM

I hope that you are right about the 10 million or under holdings. I agree that this time period for their exit was probably prearranged and that the dividends were part of the deal. It hurts to see the sp suffer at this time, but it will be worth it to have them out. I have a feeling that they have a deadline date and it may very well be the end of this month. Thank you for your input, ads

ps I found a good gift for our new CEO--

http://www.researchandmarkets.com/reportinfo.asp?report_id=519396

Share
New Message
Please login to post a reply